glp 1 drugs and alcohol GLP-1 Use Reduction: Can It Really Help? Clinical evidence has long suggested

China is expected to grow at a CAGR of 7.1%, reflecting the rising burden of diabetes in the country, along with growing access to modern therapies like GLP-1 Receptor Agonists for better diabetes management

GIP consists of 42 amino acids and is synthesized and secreted by endocrine K cells located mainly in the proximal duodenum and jejunum

Expet Opin Drug Discov

I never imagined that physicians would have to worry about our patients losing too much weight when taking an anti-obesity drug, Kushner says

However, based also on small histopathologic studies that pointed to a marked expansion of the exocrine and endocrine pancreatic compartments with the use of incretin-based therapies, the former being accompanied by increased proliferation and dysplasia and the latter by -cell hyperplasia with the potential for evolution into neuroendocrine tumors [105], concerns remain [106], and monitoring for and reporting of pancreatic adverse effects will continue [104]

Effect of exenatide use on cognitive and affective functioning in obese patients with type 2 diabetes mellitus: exenatide use mediates depressive scores through increased perceived stress levels